Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Unilever Exiting OTC Diagnostics Business With Unipath Sale

This article was originally published in The Tan Sheet

Executive Summary

Unilever plans to divest its nearly $90 mil. Unipath women's health diagnostics business, which includes the Clearblue line of home pregnancy test kits, to focus on selected consumer brands, the firm said June 19.

You may also be interested in...



Inverness Acquisition Of Unipath Could Lead To New Cardiology Diagnostics

Inverness Medical Innovations' acquisition of home pregnancy test manufacturer Unipath and its immunodiagnostic technologies could lead to new self-diagnostic tools in the cardiology arena

Inverness Acquisition Of Unipath Could Lead To New Cardiology Diagnostics

Inverness Medical Innovations' acquisition of home pregnancy test manufacturer Unipath and its immunodiagnostic technologies could lead to new self-diagnostic tools in the cardiology arena

Inverness Acquisition Of Unipath Could Lead To New Cardiology Diagnostics

Inverness Medical Innovations' acquisition of home pregnancy test manufacturer Unipath and its immunodiagnostic technologies could lead to new self-diagnostic tools in the cardiology arena

Related Content

Topics

UsernamePublicRestriction

Register

PS092732

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel